Anxo Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 824.1 million compared to TWD 866.11 million a year ago. Net income was TWD 19.23 million compared to TWD 31.4 million a year ago. Basic earnings per share from continuing operations was TWD 0.4 compared to TWD 0.65 a year ago. Diluted earnings per share from continuing operations was TWD 0.4 compared to TWD 0.65 a year ago.